Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments

Patients with chronic heart failure (HF) have a poor prognosis due to irreversible impairment of left ventricular function, with 5-year survival rates <60%. Despite advances in conventional medicines for HF, prognosis remains poor, and there is a need to improve treatment further. Cell-based ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishino, Yoshikazu, Fukuda, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046277/
https://www.ncbi.nlm.nih.gov/pubmed/36979894
http://dx.doi.org/10.3390/biomedicines11030915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046277/
https://www.ncbi.nlm.nih.gov/pubmed/36979894
http://dx.doi.org/10.3390/biomedicines11030915

Ejemplares similares